Showing posts with label placebo. Show all posts
Showing posts with label placebo. Show all posts

Saturday, 24 July 2010

Babies in the womb benefit from second dose of steroids

According to a recent research, administering a second dose of steroids to babies, still in the womb, could be beneficial to reduce the chances of post-birth respiratory problems in the future without posing any concerns in terms of baby growth.
It was revealed by study author Dr. James Kurtzman, an associate clinical professor in the division of maternal-fetal medicine in the department of obstetrics and gynecology at the University of California, Irvine, that a reduction of 31 percent was noticed in terms of overall composite neonatal morbidity when a second steroid dose was administered to babies who are born before 34 weeks.
When doctors first started giving steroids to mothers who appeared to be going into pre-term labor, they discovered that, for the babies' health, it was best if the steroid dose was given no more than seven days before delivery.
But it's not always easy to tell exactly when a woman will deliver. So, if a woman passed the seven-day mark and still had not delivered, doctors would repeat the steroid dose. However, doctors soon learned that multiple courses of steroids led to growth restriction and smaller head circumferences in the babies.
"Then the pendulum swung the other way, and doctors were holding out on giving the first dose" until they were sure the woman was going to deliver, Kurtzman explained. That resulted in some women never getting treated before delivery.
"So, we developed this study for patients that remained pregnant for more than two weeks after receiving their first course," he said.
The study included 437 women from 18 medical facilities -- both community hospitals and academic medical centers. The women were randomly assigned to receive either a second, so-called "rescue," dose of steroids closer to delivery or a placebo.
The researchers found a significant reduction in respiratory problems for babies who received the second dose of steroids. Plus, they found no evidence of growth restriction or smaller head circumferences.
The results of this study reveal that we are faring better in terms of prevention and management of premature births, as per Dr. Peter Bernstein, a maternal-fetal medicine specialist at Montefiore Medical Center in New York City.

Friday, 26 February 2010

Older women with frailty can get benefit with appetite-stimulating hormone

A hormone, ghrelin, which stimulates appetite, may be used as an effective treatment option for providing relief to older women with clinical frailty.
The finding was disclosed by a study presented by Penn Medicine researchers at ENDO, The Endocrine Society's 91st Annual Meeting.
Frailty is a common geriatric syndrome characterized by unintentional weight loss, exhaustion, weakness, and low levels of anabolic hormones prompting increase in risk of falls, hospitalizations, disability, and even death.
In the pilot study, funded by the National Institutes of Health and Penn's Institute on Aging, five frail women and five healthy women, all over the age of seventy, were randomized to receive an infusion of the hormone ghrelin or placebo. After a ghrelin transfusion, frail women in the study had a stronger, healthy appetite and increased anabolic hormone activity. The only side effect reported during the treatment was a transient sense of warmth that occurred in four women who received the ghrelin transfusion.
Now that safety and initial efficacy has been proven in this pilot study, larger follow-up studies will look at the potential therapeutic role of ghrelin or ghrelin mimetic agents in the frail population. At this time, these agents are only available for research use.
Anne Cappola, MD, ScM, Assistant Professor of Medicine in Endocrinology, Diabetes, and Metabolism at the University Of Pennsylvania School Of Medicine, remarked that efforts for identifying ways to treat or eliminate common geriatric conditions has become highly important today due to the associated severe health consequences.